Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Recurrence 1Plasmablastic Lymphoma 1Pediatric Brain Tumor 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 13Rituximab 11Prednisone 9Vincristine 8Lenalidomide 8Doxorubicin 8Bendamustine Hydrochloride 7obinutuzumab 5fludarabine 4Whole-Body Irradiation 4Magnetic Resonance Spectroscopy 4Specimen Handling 3R-CHOP protocol 3Prednisolone 3Peripheral Blood Stem Cell Transplantation 3Cyclosporine 3Biopsy 3zanubrutinib 2fludarabine phosphate 2Radiotherapy 2Oxaliplatin 2Mycophenolic Acid 2Melphalan 2Gemcitabine 2Etoposide 2Cytarabine 2venetoclax 1umbralisib 1treosulfan 1tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Carmustine × 30 days × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡